Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France

被引:0
|
作者
Didier Riethmuller
Anne-Carole Jacquard
Jean Lacau St Guily
François Aubin
Xavier Carcopino
Pierre Pradat
André Dahlab
Jean-Luc Prétet
机构
[1] CHU Saint Jacques,Service de gynécologie obstétrique
[2] Sanofi Pasteur MSD,Service d’Oto
[3] Université de Paris 6 et Faculté de Pierre et Marie Curie,rhino
[4] Assistance Publique-Hôpitaux de Paris,laryngologie et chirurgie cervico
[5] Service de dermatologie,faciale, Hôpital Tenon
[6] Centre Hospitalier Universitaire Saint-Jacques,Department of Obstetrics and Gynaecology
[7] Hôpital Nord,Department of Hepatology
[8] Assistance Publique des Hôpitaux de Marseille (APHM),undefined
[9] Aix-Marseille Université (AMU),undefined
[10] CNRS,undefined
[11] IRD,undefined
[12] Avignon Université,undefined
[13] IMBE UMR 7263,undefined
[14] Hôpital de la Croix-Rousse,undefined
[15] Hospices Civils de Lyon,undefined
[16] Université Franche-Comte,undefined
[17] EA 3181,undefined
[18] FED4234,undefined
[19] LabEx LipSTIC ANR-11-LABX-0021,undefined
[20] CIC-BT 506,undefined
[21] CHRU Besançon,undefined
来源
关键词
HPV; Human papillomavirus; Vaccine; Invasive cervical cancer; Cervical intraepithelial neoplasia; Genital warts; Anal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
    Bosco, Liana
    Serra, Nicola
    Fasciana, Teresa
    Pistoia, Daniela
    Vella, Marco
    Di Gregorio, Leonardo
    Schillaci, Rosaria
    Perino, Antonino
    Calagna, Gloria
    Firenze, Alberto
    Capra, Giuseppina
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [12] Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases
    Diakite, Ibrahim
    Nguyen, Sylvi
    Sabale, Ugne
    Pavelyev, Andrew
    Saxena, Kunal
    Tajik, Athar Ali
    Wang, Wei
    Palmer, Cody
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1085 - 1098
  • [13] Reducing the Economic Burden of HPV-Related Diseases
    Mayeaux, Edward John, Jr.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (04): : S2 - S7
  • [14] HPV-related Diseases of the female Genital Tract
    Schmidt, D.
    PATHOLOGE, 2011, 32 (06): : 449 - 450
  • [15] The Role of the Male in Preventing HPV-Related Diseases
    Andrews, Jeffrey C.
    Lawson, Herschel W.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2016, 20 (03) : 195 - 196
  • [16] Are we closer to the prevention of HPV-related diseases?
    Harper, DM
    JOURNAL OF FAMILY PRACTICE, 2005, : S10 - S16
  • [17] Anti-HPV vaccination in women treated for HPV-related lesions: effective vaccination strategy for achieving HPV-related diseases control
    Calabro, Giovanna Elisa
    Carini, Elettra
    Basile, Michele
    Bonanni, Paolo
    De Vincenzo, Rosa
    Ghelardi, Alessandro
    Tafuri, Silvio
    Conversano, Michele
    Favaretti, Carlo
    Cicchetti, Americo
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2020, 17 (02) : 1 - 8
  • [18] Evaluating the impact of HPV-related diseases - Cervical cancer and genital warts
    Brotzman, GL
    JOURNAL OF FAMILY PRACTICE, 2005, : S3 - S9
  • [19] Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
    Drolet, Melanie
    Laprise, Jean-Francois
    Boily, Marie-Claude
    Franco, Eduardo L.
    Brisson, Marc
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) : 2264 - 2268